VIDEO

FindCenter AddIcon

There Is No Such Thing as a “Bad Drug” | Psychedcast Ft. Mark Haden

By Mark Haden — 2020

Mark Haden is the executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS) Canada as well as an adjunct professor at the University of British Columbia School of Public and Population Health.

30:35 min

Ketamine Therapy Is Going Mainstream. Are We Ready?

The mind-altering drug has been shown to help people suffering from anxiety and depression. But how it helps, who it will serve, and who will profit are open questions.

Article
Emily Witt
2021
FindCenter AddIcon

A Dose of a Hallucinogen from a ‘Magic Mushroom,’ and then Lasting Peace

Two studies used psilocybin to see if the drug could reduce depression and anxiety in cancer patients. The results were striking.

Article
Jan Hoffman
2016
FindCenter AddIcon

EXPLORE TOPIC

Drug Policy